Early preclinical work in RT112 bladder cancer cell lines suggests that resistance to EV is mainly mediated by resistance to the MMAE payload and seems to be independent of the expression of surface target Nectin-4 [117]. The gene discussed is NECTIN4; the disease is urinary bladder cancer.